The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Curious about accumulating points? Learn which card is best for accumulating points and elevate your rewards strategy effectively.
24,231 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Mark Cuban has embraced a Mac Mini to fight an AI-generated flood of emails, aiming to keep his inbox under control. ...
SoFi Technologies is redefining fintech with a multi-product model that blends digital banking, lending, and crypto. ...
March brought a mix of regulatory headlines and upbeat AI-related gains. This article breaks down what happened in th...
Volatility is real and headlines can be alarming. Yet many individual investors continue to buy stocks. This guide ex...
Binance unveils a regional communications push, introduces new perpetual contracts, and plans to drop select trading ...
Gabe Bodner, a veteran lender now leading OneTrust Home Loans' reverse mortgage unit, outlined a branding-focused str...
The jeffrey epstein mystery deepens as a disputed note stirs questions about truth, trust, and how the wealthy plan f...
A straightforward, low-cost Vanguard strategy could outpace the S&P 500 in 2026. This guide explains why and shows co...
Investors are weighing whether the late micron technology stock still offers upside after a stunning rally. This guid...
A major insider purchase often sparks questions about a stock's future. This breakdown examines what the 125,000-shar...
Hive Digital Technologies stock rallied after a bold AI infrastructure plan caught investors' attention. This article...